| For: | Souza-Tavares H, Miranda CS, Vasques-Monteiro IML, Sandoval C, Santana-Oliveira DA, Silva-Veiga FM, Fernandes-da-Silva A, Souza-Mello V. Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas. World J Gastroenterol 2023; 29(26): 4136-4155 [PMID: 37475842 DOI: 10.3748/wjg.v29.i26.4136] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i26/4136.htm |
| Number | Citing Articles |
| 1 |
Mohammed A. Abdel-Rasol, Wael M. El-Sayed. Nuclear receptors in metabolic, inflammatory, and oncologic diseases: mechanisms, therapeutic advances, and future directions. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-03073-6
|
| 2 |
In Silico Toxicological Analysis of Active Compounds Present in Selected Pesticides Sold in South-West Nigeria. JURNAL KESEHATAN LINGKUNGAN 2024; 16(3) doi: 10.20473/jkl.v16i3.2024.200-212
|
| 3 |
Jingtian Yang, Jialin Li, Wuzhi Jiaba, Jing Yuan, Mengling Yu, Lingliang Guan, Guoyu Yang. Integrated Metabolomic and Transcriptomic Analyses Elucidate Phenolic Acid Diversity and Their Antioxidant and Functional Associations in Ocimum Species. Journal of Agricultural and Food Chemistry 2026; 74(8) doi: 10.1021/acs.jafc.5c13602
|
| 4 |
Shotaro Kamata, Akihiro Honda, Nonoka Kashiwagi, Ayumi Shimamura, Sayaka Yashiro, Yuna Komori, Aoi Hosoda, Noriyuki Akahoshi, Isao Ishii. Different Coactivator Recruitment to Human PPARα/δ/γ Ligand-Binding Domains by Eight PPAR Agonists to Treat Nonalcoholic Fatty Liver Disease. Biomedicines 2024; 12(3) doi: 10.3390/biomedicines12030624
|
| 5 |
R. Sowmya, S. Karthick Raja Namasivayam, G.S. Amrish Varshan, Krithika Shree Sivasuriyan. Computational network pharmacology and bioassays to unveil the antidiabetic mechanism of Mukia maderasapatana-mediated selenium nanoparticles. Computational Biology and Chemistry 2026; 122 doi: 10.1016/j.compbiolchem.2026.108901
|
| 6 |
Xiangyang Wang, Yilei Liu, Yaxiong Zhou, Min Li, Tingting Mo, Xiaoping Xu, Zhiyuan Chen, Yu Zhang, Li Yang. mTORC2 knockdown mediates lipid metabolism to alleviate hyperlipidemic pancreatitis through PPARα. Journal of Biochemical and Molecular Toxicology 2024; 38(8) doi: 10.1002/jbt.23802
|
| 7 |
Qiang Chen, Wenyan Chi, Weiqi Wang, Ming Zhu, Meiqi Sun, Yue Luan, Yanxu Zhang, Zhidong Qiu, Ye Qiu. Eleutheroside B liposomes ameliorate type 2 diabetes mellitus by modulating glucose and lipid metabolism: A metabolomic study. Phytomedicine 2026; 150 doi: 10.1016/j.phymed.2025.157628
|
| 8 |
Francine R. F. Silva, Joyce E. Heredia, Bruna C. Oliveira, Onno J. Arntz, Talita Martins, Eduardo H. M. Nunes, Mauro M. Teixeira, Tarcilia A. Silva, Fons A. J. van de Loo, Soraia Macari, Adaliene V. M. Ferreira, Marina C. Oliveira. Bovine Milk Extracellular Vesicles Modulate Alveolar Bone Microarchitecture and Mitigate Hepatic Steatosis in Obese Mice Fed a High‐Fat Diet. Molecular Nutrition & Food Research 2026; 70(3) doi: 10.1002/mnfr.70400
|
| 9 |
Motahareh Taghizadeh, Mohammad Hasan Maleki, Omid Vakili, Ramin Tavakoli, Parvin Zarei, Amirreza Dehghanian, Hossein Bordbar, Sayed Mohammad Shafiee. Bilirubin, a hepatoprotective agent that activates SIRT1, PGC-1α, and PPAR-α, while inhibiting NF-κB in rats with metabolic-associated fatty liver disease. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-80119-5
|
| 10 |
Fahrul Nurkolis, Jacques Delarue, Vincent Lau, Rony Abdi Syahputra, Apollinaire Tsopmo, Hardinsyah Hardinsyah, Miguel A. Prieto, Nurpudji Astuti Taslim, Trina Ekawati Tallei, Raymond Rubianto Tjandrawinata, Antonello Santini. Global Mapping of Flavonoids in Fruits and Vegetables: Targeting Insulin Receptors, GLP‐1R, and PPARs to Mitigate Diabetes. Phytotherapy Research 2026; 40(1) doi: 10.1002/ptr.70116
|
| 11 |
Jian Jin, Yang Li, Xiande Liu, Chunmei Yan, Zhiqiang Cheng, Yannian Wu, Zhiyong Wang, Dongling Zhang. Alternative Splicing Events and Differently Expressed Genes During Peak Mortality in Large Yellow Croaker (Larimichthys crocea) Infected with Scuticociliate. Marine Biotechnology 2025; 27(1) doi: 10.1007/s10126-025-10413-4
|
| 12 |
Keilah Valéria Naves Cavalcante, Marcos Divino Ferreira-Junior, Marina Conceição dos Santos Moreira, Stefanne Madalena Marques, James Oluwagbamigbe Fajemiroye, Rosiane Aparecida Miranda, Patrícia Cristina Lisboa, Egberto Gaspar de Moura, Carlos Henrique Xavier, Eduardo Colombari, Rodrigo Mello Gomes, Gustavo Rodrigues Pedrino. Skinny fat model of metabolic syndrome induced by a high-salt/sucrose diet in young male rats. British Journal of Nutrition 2025; 133(2) doi: 10.1017/S0007114524002927
|
| 13 |
Isabela Macedo Lopes Vasques-Monteiro, Aline Fernandes-da-Silva, Carolline Santos Miranda, Flavia Maria Silva-Veiga, Julio Beltrame Daleprane, Vanessa Souza-Mello. Anti-steatotic effects of PPAR-alpha and gamma involve gut-liver axis modulation in high-fat diet-fed mice. Molecular and Cellular Endocrinology 2024; 585 doi: 10.1016/j.mce.2024.112177
|
| 14 |
Esmail Karami, Fatemeh Rostamkhani, Maasoume Abdollahi, Mohamadreza Ahmadifard. Targeting the UCP1-dependent thermogenesis pathway with CRISPR/Cas9: a new approach to obesity management. Current Research in Biotechnology 2025; 9 doi: 10.1016/j.crbiot.2025.100295
|
| 15 |
Amedeo Lonardo, Ralf Weiskirchen. PPARs in molecular pathogenesis and drug treatment of type 2 diabetes-related MASLD. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100590
|
| 16 |
Aparna Eledath Kolasseri, Ramasamy Tamizhselvi, Sivaraman Jayanthi. Decoding the Methylome: Insights into the Epigenetic Regulation of Polycystic Ovarian Syndrome through Mitochondrial DNA Methylation. Current Genomics 2026; 26(6) doi: 10.2174/0113892029401274251009070350
|
| 17 |
Marco Rendine, Samuele Venturi, Mirko Marino, Claudio Gardana, Peter Møller, Daniela Martini, Patrizia Riso, Cristian Del Bo. Effects of Quercetin Metabolites on Glucose‐Dependent Lipid Accumulation in 3T3‐L1 Adipocytes. Molecular Nutrition & Food Research 2025; 69(15) doi: 10.1002/mnfr.70070
|
| 18 |
Maria Vasileiou, Sotirios Charalampos Diamantoudis, Christina Tsianava, Nam P. Nguyen. Therapeutic Potential and Challenges of Pioglitazone in Cancer Treatment. Applied Sciences 2025; 15(4) doi: 10.3390/app15041925
|
| 19 |
Flavia Maria Silva-Veiga, Aline Fernandes-da-Silva, Henrique Souza-Tavares, Daiana Araújo Santana-Oliveira, Vanessa Souza-Mello. Pharmacological Targets in Metabolic Diseases. 2026; doi: 10.1016/B978-0-443-27370-4.00015-9
|
| 20 |
Chen-Ying Zhu, Pei-Han Yu, Qi Sun, De-Fei Hong, Chang Yang, Hua Naranmandura. Nuclear receptors in metabolism and diseases: Mechanistic and therapeutic insights. Pharmacological Research 2025; 218 doi: 10.1016/j.phrs.2025.107862
|
| 21 |
Ya Cao, Zhengrong Wen, Jiachuan Chen, Huangyan Zhang, Qiaoyang Li, Zongqiang Hu. USP47 alleviates metabolic-associated fatty liver disease by activating the PPARα signaling pathway through the stabilization of SIRT1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2026; 1872(5) doi: 10.1016/j.bbadis.2026.168232
|
| 22 |
Xiaoyang Zhu, Qing Liu, Andrew D. Patterson, Arun K. Sharma, Shantu G. Amin, Samuel M. Cohen, Frank J. Gonzalez, Jeffrey M. Peters. Accumulation of Linoleic Acid by Altered Peroxisome Proliferator-Activated Receptor-α Signaling Is Associated with Age-Dependent Hepatocarcinogenesis in Ppara Transgenic Mice. Metabolites 2023; 13(8) doi: 10.3390/metabo13080936
|
| 23 |
Yun Zhao, Chen Wang, Ya-ling Li, Xu-jiao Li, Hong-yong Ding, Ci-ning Liu, Li-mei Zhang, Xiang-shan Ji, Lan-ping Yu, Zhi-wei Qiu, Ling-ding Meng, Qi-bo Huang, Hui Wang. Effects of bile acids supplementation in feed on digestive capacity, antioxidant capacity, lipid metabolism, and intestinal microorganisms in Yellow River carp (Cyprinus carpio). Aquaculture Reports 2024; 36 doi: 10.1016/j.aqrep.2024.102096
|
| 24 |
Pierre-Louis Batrow, Sylvie Caspar-Bauguil, Nathalie Rochet, Nadine Gautier, Anne-Sophie Rousseau, Marielle Maret, Samah Rekima, Etienne Mouisel, Emmanuel Van Obberghen, Christian H. Roux, Hervé Guillou, Catherine Postic, Christian Wolfrum, Dominique Langin, Ez-Zoubir Amri, Isabelle Mothe-Satney. Deletion of PPARα in mouse brown adipocytes increases their De Novo Lipogenesis. Molecular Metabolism 2025; 98 doi: 10.1016/j.molmet.2025.102184
|
| 25 |
Exploration of Glitazone/Thiazolidinedione Derivatives: Molecular Design and Therapeutic Potential. Bioengineering 2025; 12(10) doi: 10.3390/bioengineering12101024
|
| 26 |
Yousef M. Almoghrabi, Basmah M. Eldakhakhny, Ghada Ajabnoor, Faisal Alandejani, Ahmad Jamal, Dareen Alyousfi, Ahmad M. Alzahrani, Mostafa A. Elsamanoudy, Taghreed Shamrani, Ayman Z. Elsamanoudy. Molecular pathways, tissue-specific roles, and therapeutic opportunities in mitochondrial resilience-based strategies for insulin resistance. Frontiers in Clinical Diabetes and Healthcare 2026; 7 doi: 10.3389/fcdhc.2026.1790182
|
| 27 |
Sara Paola Mambrini, Antonio Grillo, Santo Colosimo, Francesco Zarpellon, Giorgia Pozzi, Davide Furlan, Gabriele Amodeo, Simona Bertoli. Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1426551
|
| 28 |
Li‐You Lian, Tianyi Xia, Zhong‐Wei Chen, Cai‐Yun Wen, Xiao‐Dong Zhou, Tie Xiao, Giovanni Targher, Christopher D. Byrne, Yee Hui Yeo, Shenghong Ju, Wen‐Yue Liu, Ming‐Hua Zheng. Liver‐Pancreas Fat Deposition: Impact on Cardiometabolic Multimorbidity and Cardiac Dysfunction. Liver International 2026; 46(3) doi: 10.1111/liv.70548
|
| 29 |
Jing Liu, Xiaozhen Tan, Xia Fang, Xinxu Ge, Linghao Xu, Yang Long, Xiaobing Mao, Yong Xu. Deubiquitinating enzymes as therapeutic targets in diabetic nephropathy. Trends in Pharmacological Sciences 2026; 47(2) doi: 10.1016/j.tips.2025.07.015
|
| 30 |
Neda Shakour, Mohammad Reza Mahdinezhad, Fereshteh Asgharzadeh, Majid Khazaei, Luis E. Simental-Mendía, Nema Mohamadian Roshan, Amirhossein Sahebkar, Farzin Hadizadeh. Antioxidant effects of a novel pioglitazone analogue (PA9) in a rat model of diabetes: Modulation of redox homeostasis and preservation of tissue architecture. Journal of Diabetes and its Complications 2024; 38(12) doi: 10.1016/j.jdiacomp.2024.108897
|
| 31 |
Snehal Misal, Vijay M. Patil, C.S. Ramaa, Antonio Lavecchia. Peroxisome proliferator-activated receptor antagonists as emerging therapeutics in cancer treatment. Bioorganic Chemistry 2025; 163 doi: 10.1016/j.bioorg.2025.108693
|
| 32 |
Wenlan Li, Guoping Qiu, Manjun Kang, Can Zhang, Wei Quan, Hui Zhou, Xiankang Fan, Jie Luo, Baiyi Lu, Maiquan Li. Insights into the dual inhibitory effects of phenylethanoid glycosides from Osmanthus fragrans flower on glycolipid metabolizing enzymes. Bioorganic Chemistry 2026; 168 doi: 10.1016/j.bioorg.2025.109328
|
| 33 |
Vanessa Souza-Mello. Pharmacological Targets in Metabolic Diseases. 2026; doi: 10.1016/B978-0-443-27370-4.00003-2
|
| 34 |
Faiz-ul Hassan, M. Saif-ur Rehman, Maryam Javed, Khalil Ahmad, Israr Fatima, Muhammad Safdar, Noman Ashraf, Asif Nadeem. Identification of phytochemicals as putative ligands for the targeted modulation of peroxisome proliferator‐activated receptor α (PPARα) in animals. Journal of Biomolecular Structure and Dynamics 2024; 42(22) doi: 10.1080/07391102.2023.2268185
|
| 35 |
Mehmet Ali Gul, Duygu Tozcu, Akın Tekcan, Mustafa Capraz, Hatice Dortok Demir. Serum adiponectin and peroxisome proliferator-activated receptors-γ levels in obese patients with and without prediabetes. Revista da Associação Médica Brasileira 2024; 70(3) doi: 10.1590/1806-9282.20231000
|